China's API extortion from Indian pharma breaking down
The API coming from China started getting dumped in India at very low prices.
api
April 2024
March 2023
October 2022
October 2021
March 2021
June 2019
Incentive boosters to help Indian API industry grow at 7-8% over 3-4 years
India imported ₹35,000 crore worth of APIs and bulk drugs in FY22, accounting for 35% of its total API requirement, of which China accounted for 65-70% share.
The API Man of Laurus
With several years of experience in the pharma industry, Satyanarayana Chava has catapulted Laurus among the top global R&D firms.
Quality issues remain for Indian pharma companies: USFDA
The problems faced by FDA’s investigators in India are similar to those around the world, US Food and Drug Administration spokesperson Jeremy Kahn tells Fortune India.
Way ahead: A tech-savvy makeover for retail banking
The Covid-19 disruption has ignited a new era of value-based customer-centric banking. It has also given rise to platform and data-driven approaches, signalling a radical change in retail banking.
Powered by text, Route Mobile soars
Route Mobile, a cloud communications platform for enterprises, has had a dream run on the bourses since its listing last year. At the core of this success is the humble text message.
API developer Postman raises $50 million
Founded in Bengaluru and now headquartered in San Francisco, Postman’s Series B round of fundraise will further accelerate its growth in the API ecosystem.
